From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program

Gary T Ko, Wing-Yee So, Peter C Tong, Francois Le Coguiec, Debborah Kerr, Greg Lyubomirsky, Beaver Tamesis, Troels Wolthers, Jennifer Nan, Juliana Chan, Gary T Ko, Wing-Yee So, Peter C Tong, Francois Le Coguiec, Debborah Kerr, Greg Lyubomirsky, Beaver Tamesis, Troels Wolthers, Jennifer Nan, Juliana Chan

Abstract

Background: The Joint Asia Diabetes Evaluation (JADE) Program is a web-based program incorporating a comprehensive risk engine, care protocols, and clinical decision support to improve ambulatory diabetes care.

Methods: The JADE Program uses information technology to facilitate healthcare professionals to create a diabetes registry and to deliver an evidence-based care and education protocol tailored to patients' risk profiles. With written informed consent from participating patients and care providers, all data are anonymized and stored in a databank to establish an Asian Diabetes Database for research and publication purpose.

Results: The JADE electronic portal (e-portal: http://www.jade-adf.org) is implemented as a Java application using the Apache web server, the mySQL database and the Cocoon framework. The JADE e-portal comprises a risk engine which predicts 5-year probability of major clinical events based on parameters collected during an annual comprehensive assessment. Based on this risk stratification, the JADE e-portal recommends a care protocol tailored to these risk levels with decision support triggered by various risk factors. Apart from establishing a registry for quality assurance and data tracking, the JADE e-portal also displays trends of risk factor control at each visit to promote doctor-patient dialogues and to empower both parties to make informed decisions.

Conclusions: The JADE Program is a prototype using information technology to facilitate implementation of a comprehensive care model, as recommended by the International Diabetes Federation. It also enables health care teams to record, manage, track and analyze the clinical course and outcomes of people with diabetes.

Figures

Figure 1
Figure 1
Logistics and components of the web-based electronic portal of the JADE Program.
Figure 2
Figure 2
The JADE electronic portal provides templates to guide users to collect relevant data during the annual comprehensive assessment.
Figure 3
Figure 3
The JADE Risk Engine estimates the 5-year probability of major clinical events.
Figure 4
Figure 4
The JADE e-portal displays the risk level of the patients, supplemented by decision and self management support triggered by various risk factors which can be printed in 5 Asian languages.

References

    1. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–2140. doi: 10.1001/jama.2009.726.
    1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681–1688. doi: 10.1016/S0140-6736(06)69703-1.
    1. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28(9):2130–2135. doi: 10.2337/diacare.28.9.2130.
    1. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–869. doi: 10.1056/NEJMoa011161.
    1. HPSCG. Heart Protection Study Collaborative Group (HPSCG). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22. doi: 10.1016/S0140-6736(02)09327-3.
    1. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591. doi: 10.1056/NEJMoa0706245.
    1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi: 10.1056/NEJMoa0806470.
    1. So WY, Yang X, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry. Diabetes Metab Res Rev. 2008;24(3):238–246. doi: 10.1002/dmrr.792.
    1. Yang X, So WY, Kong AP, Ho CS, Lam CW, Stevens RJ, Lyu RR, Yin DD, Cockram CS, Tong PC. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care. 2007;30(1):65–70. doi: 10.2337/dc06-1273.
    1. Yang X, So WY, Kong AP, Ma RC, Ko GT, Ho CS, Lam CW, Cockram CS, Chan JC, Tong PC. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol. 2008;101(5):596–601. doi: 10.1016/j.amjcard.2007.10.019.
    1. Yang XL, So WY, Kong AP, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC, Cockram CS. Modified end-stage renal disease risk score for Chinese type 2 diabetic patients--the Hong Kong Diabetes Registry. Diabetologia. 2007;50(6):1348–1350. doi: 10.1007/s00125-007-0639-7.
    1. Yang X, So WY, Tong PC, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC. Development and validation of an all-cause mortality risk score in type 2 diabetes. Arch Intern Med. 2008;168(5):451–457. doi: 10.1001/archinte.168.5.451.
    1. Yang X, Ko GT, So WY, Ma RC, Yu LW, Kong AP, Zhao H, Chow CC, Tong PC, Chan JC. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes. 2010;59(5):1254–1260. doi: 10.2337/db09-1371.
    1. Yang X, So WY, Ma RC, Ko GT, Kong AP, Zhao H, Luk AO, Lam CW, Ho CS, Tong PC. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care. 2009;32(10):1826–1832. doi: 10.2337/dc09-0725.
    1. Chan JC, Cockram CS. In: International Textbook of Diabetes Mellitus. Third. DeFronzo A, Feranninni E, Keen H, Zimmet P, editor. John, Wiley & Son; 2004. Organization of diabetes care - Western Pacific Region (Hong Kong and China as example)
    1. Kong AP, Yang X, Ko GT, So WY, Chan WB, Ma RC, Ng VW, Chow CC, Cockram CS, Tong PC. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care. 2007;30(4):953–959. doi: 10.2337/dc06-2443.
    1. Leung WY, So WY, Tong PC, Chan NN, Chan JC. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med. 2005;118(12):1414. doi: 10.1016/j.amjmed.2005.07.050.
    1. So WY, Tong PC, Ko GT, Leung WY, Chow CC, Yeung VT, Chan WB, Critchley JA, Cockram CS, Chan JC. Effects of protocol-driven care versus usual outpatient clinic care on survival rates in patients with type 2 diabetes. Am J Manag Care. 2003;9(9):606–615.
    1. Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, Chan JC. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006;333(7567):522. doi: 10.1136/bmj.38905.447118.2F.
    1. So WY, Chan JC. In: Textbook of Diabetes. Goldstein DB, editor. Cockram CS: Blackwell; 2010. The role of the multidisciplinary team. in press .
    1. Baker AM, Lafata JE, Ward RE, Whitehouse F, Divine G. A Web-based diabetes care management support system. Jt Comm J Qual Improv. 2001;27(4):179–190.
    1. Morris AD, Boyle DI, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW, MacDonald TM. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration. BMJ. 1997;315(7107):524–528.
    1. Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care. 2001;24(9):1547–1555. doi: 10.2337/diacare.24.9.1547.
    1. Sonksen P, Williams C. Information technology in diabetes care 'Diabeta': 23 years of development and use of a computer-based record for diabetes care. Int J Biomed Comput. 1996;42(1-2):67–77. doi: 10.1016/0020-7101(96)81526-1.
    1. Weber V, Bloom F, Pierdon S, Wood C. Employing the electronic health record to improve diabetes care: a multifaceted intervention in an integrated delivery system. J Gen Intern Med. 2008;23(4):379–382. doi: 10.1007/s11606-007-0439-2.
    1. Wells S, Furness S, Rafter N, Horn E, Whittaker R, Stewart A, Moodabe K, Roseman P, Selak V, Bramley D. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice. Eur J Cardiovasc Prev Rehabil. 2008;15(2):173–178. doi: 10.1097/HJR.0b013e3282f13af4.
    1. IDF. International Diabetes Federation (IDF) Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006;23(6):579–593. doi: 10.1111/j.1464-5491.2006.01918.x.
    1. Chan JC, So WY, Ko GT, Tong PC, Yang X, Ma RC, Kong AP, Wong R, Le Coguiec F, Tamesis B. The Joint Asia Diabetes Evaluation (JADE) Program: A Web-based Program To Translate Evidence To Clinical Practice in Type 2 Diabetes. Diabet Med. 2009;26:693–699. doi: 10.1111/j.1464-5491.2009.02751.x.
    1. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870–878. doi: 10.1056/NEJMoa011489.
    1. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853. doi: 10.1016/S0140-6736(98)07019-6.
    1. UKPDS. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):713–720.
    1. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145–153. doi: 10.1056/NEJM200001203420301.
    1. Chan JC, So WY, Yeung CY, Ko GT, Lau IT, Tsang MW, Lau KP, Siu SC, Li JK, Yeung VT. Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study. Diabetes Care. 2009;32(6):977–982. doi: 10.2337/dc08-1908.
    1. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362(9391):1225–1230. doi: 10.1016/S0140-6736(03)14546-1.
    1. Narayan KM, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DF, Vinicor F. Translation research for chronic disease: the case of diabetes. Diabetes Care. 2000;23(12):1794–1798. doi: 10.2337/diacare.23.12.1794.
    1. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144(7):465–474.
    1. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136(8):565–574.
    1. Leung WY, So WY, Tong PC, Lo MK, Lee KF, Ko GT, Chan WB, Cockram CS, Brenner BM, Shahinfar S. The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathy. Nephrol Dial Transplant. 2004;19(10):2519–2525. doi: 10.1093/ndt/gfh408.
    1. Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, Ilkova H, Ramachandran A, Aschner P. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS) Diabetes Care. 2009;32(2):227–233. doi: 10.2337/dc08-0435.
    1. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi: 10.1681/ASN.2006040368.
    1. Piatt GA, Orchard TJ, Emerson S, Simmons D, Songer TJ, Brooks MM, Korytkowski M, Siminerio LM, Ahmad U, Zgibor JC. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care. 2006;29(4):811–817. doi: 10.2337/diacare.29.04.06.dc05-1785.
    1. Ko GT, So WY, Tong PC, Chan WB, Yang X, Ma RC, Kong AP, Ozaki R, Yeung CY, Chow CC. Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus. CMAJ. 2009;180(9):919–926.
    1. Luk AO, Yang X, Ma RC, Ng VW, Yu LW, Lau WW, Ozaki R, Chow FC, Kong AP, Tong PC. Association of statin use and development of renal dysfunction in type 2 diabetes-The Hong Kong Diabetes Registry. Diabetes Res Clin Pract. 2010. in press .
    1. Tong PC, Ko GT, So WY, Chiang SC, Yang X, Kong AP, Ozaki R, Ma RC, Cockram CS, Chow CC. Use of anti-diabetic drugs and glycaemic control in type 2 diabetes-tThe Hong Kong Diabetes Registry. Diabetes Res Clin Pract. 2008;82(3):346–352. doi: 10.1016/j.diabres.2008.09.006.
    1. Bu D, Pan E, Walker J, Adler-Milstein J, Kendrick D, Hook JM, Cusack CM, Bates DW, Middleton B. Benefits of information technology-enabled diabetes management. Diabetes Care. 2007;30(5):1137–1142. doi: 10.2337/dc06-2101.
    1. Green CJ, Fortin P, Maclure M, Macgregor A, Robinson S. Information system support as a critical success factor for chronic disease management: Necessary but not sufficient. Int J Med Inform. 2006;75(12):818–828. doi: 10.1016/j.ijmedinf.2006.05.042.
    1. Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho CS, Cockram CS, Wong VC, Tong PC. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry. Cardiovasc Diabetol. 2007;6:37. doi: 10.1186/1475-2840-6-37.
    1. Yang XL, So WY, Kong AP, Clarke P, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetologia. 2006;49(10):2299–2308. doi: 10.1007/s00125-006-0376-3.
    1. ADA. American Diabetes Association (ADA). Clinical practice recommendations 2007. Diabetes Care. 2007;30(Suppl 1):S1–S103.
    1. APDPG. Type 2 diabetes practical targets and Treatment. Singapore: International Diabetes Institute: Melbourne, and In vivo Communications (Asia) Pte Limited; 2005. Asian-Pacific Type 2 Diabetes Policy Group (APDPG)
    1. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565–1576. doi: 10.1056/NEJMoa0806359.
    1. Tang YH, Pang SM, Chan MF, Yeung GS, Yeung VT. Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitus. J Adv Nurs. 2008;62(1):74–83. doi: 10.1111/j.1365-2648.2007.04526.x.
    1. Wu SF, Courtney M, Edwards H, McDowell J, Shortridge-Baggett LM, Chang PJ. Self-efficacy, outcome expectations and self-care behaviour in people with type 2 diabetes in Taiwan. J Clin Nurs. 2007;16(11C):250–257. doi: 10.1111/j.1365-2702.2006.01930.x.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere